144 related articles for article (PubMed ID: 22898004)
1. Laminin-5 is a biomarker of invasiveness in cervical adenocarcinoma.
Imura J; Uchida Y; Nomoto K; Ichikawa K; Tomita S; Iijima T; Fujimori T
Diagn Pathol; 2012 Aug; 7():105. PubMed ID: 22898004
[TBL] [Abstract][Full Text] [Related]
2. Laminin-5 as a marker of invasiveness in cervical lesions.
Skyldberg B; Salo S; Eriksson E; Aspenblad U; Moberger B; Tryggvason K; Auer G
J Natl Cancer Inst; 1999 Nov; 91(21):1882-7. PubMed ID: 10547396
[TBL] [Abstract][Full Text] [Related]
3. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Asaka S; Nakajima T; Momose M; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2019 Jan; 474(1):79-86. PubMed ID: 30324235
[TBL] [Abstract][Full Text] [Related]
4. Laminin-5 gamma2 chain immunohistochemistry facilitates the assessment of invasiveness and improves the diagnostic reproducibility of glandular lesions of the cervix uteri.
Negri G; Romano F; Vittadello F; Kasal A; Mazzoleni G; Colombetti V; Egarter-Vigl E
Hum Pathol; 2006 Jun; 37(6):704-10. PubMed ID: 16733211
[TBL] [Abstract][Full Text] [Related]
5. Tissue-based Immunohistochemical Biomarker Accuracy in the Diagnosis of Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review of the Literature and Meta-Analysis.
Lee S; Rose MS; Sahasrabuddhe VV; Zhao R; Duggan MA
Int J Gynecol Pathol; 2017 Jul; 36(4):310-322. PubMed ID: 27801764
[TBL] [Abstract][Full Text] [Related]
6. Expression of HNF-1β in cervical carcinomas: an immunohistochemical study of 155 cases.
Němejcová K; Cibula D; Dundr P
Diagn Pathol; 2015 Mar; 10():8. PubMed ID: 25884453
[TBL] [Abstract][Full Text] [Related]
7. Basement membrane of cervical adenocarcinoma: an immunoperoxidase study of laminin and type IV collagen.
Yavner DL; Dwyer IM; Hancock WW; Ehrmann RL
Obstet Gynecol; 1990 Dec; 76(6):1014-9. PubMed ID: 2234709
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma of the Uterine Cervix Involving the Genitourinary Tract: A Potential Diagnostic Dilemma.
Schwartz LE; Khani F; Bishop JA; Vang R; Epstein JI
Am J Surg Pathol; 2016 Jan; 40(1):27-35. PubMed ID: 26426382
[TBL] [Abstract][Full Text] [Related]
9. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia.
Umezaki K; Sanezumi M; Okada H; Okamura A; Tsubra A; Kanazaki H
Gynecol Oncol; 1997 Sep; 66(3):393-8. PubMed ID: 9299251
[TBL] [Abstract][Full Text] [Related]
10. Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia.
Tsuji T; Togami S; Nomoto M; Higashi M; Fukukura Y; Kamio M; Yonezawa S; Douchi T
Histopathology; 2011 Jul; 59(1):55-62. PubMed ID: 21771026
[TBL] [Abstract][Full Text] [Related]
11. Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix.
Jaworski RC
Semin Diagn Pathol; 1990 Aug; 7(3):190-204. PubMed ID: 2171126
[TBL] [Abstract][Full Text] [Related]
12. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions.
Mikami Y; McCluggage WG
Adv Anat Pathol; 2013 Jul; 20(4):227-37. PubMed ID: 23752085
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.
Stolnicu S; Barsan I; Hoang L; Patel P; Chiriboga L; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Pike MC; Oliva E; Park KJ; Soslow RA
Am J Surg Pathol; 2018 Aug; 42(8):989-1000. PubMed ID: 29851704
[TBL] [Abstract][Full Text] [Related]
14. Synchronous Cervical Minimal Deviation Adenocarcinoma, Gastric Type Adenocarcinoma and Lobular Endocervical Glandular Hyperplasia Along with STIL in Peutz-Jeghers Syndrome: Eliciting Oncogenesis Pathways.
Neyaz A; Husain N; Deodhar M; Khurana R; Shukla S; Arora A
Turk Patoloji Derg; 2019; 35(3):247-253. PubMed ID: 28832082
[TBL] [Abstract][Full Text] [Related]
15. Adenocarcinoma of the cervix involving the fallopian tube mucosa: report of a case.
Deel CD; Allen RA; Holman LL; Zuna RE
Diagn Pathol; 2016 Aug; 11(1):77. PubMed ID: 27530463
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K
Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
[TBL] [Abstract][Full Text] [Related]
17. The relationship of glands to thick-wall blood vessels as a marker of invasion in endocervical adenocarcinoma.
Wheeler DT; Kurman RJ
Int J Gynecol Pathol; 2005 Apr; 24(2):125-30. PubMed ID: 15782068
[TBL] [Abstract][Full Text] [Related]
18. Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.
Volgareva G; Zavalishina L; Andreeva Y; Frank G; Krutikova E; Golovina D; Bliev A; Spitkovsky D; Ermilova V; Kisseljov F
BMC Cancer; 2004 Aug; 4():58. PubMed ID: 15339339
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the antigenicity of amylase in cervical glandular atypia, adenocarcinoma in situ and invasive adenocarcinoma.
Griffin NR; Wells M; Fox H
Histopathology; 1989 Sep; 15(3):267-79. PubMed ID: 2478438
[TBL] [Abstract][Full Text] [Related]
20. Fascin expression in endocervical neoplasia: correlation with tumour morphology and growth pattern.
Stewart CJ; Crook M; Loi S
J Clin Pathol; 2012 Mar; 65(3):213-7. PubMed ID: 22128198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
